Search results :

Neostigmine

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: N07AA01, S01EB06

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6
Anaphylactic shock Anaphylactic shock postmarketing x x x x x x
Arrhythmia Arrhythmia postmarketing x x x x x x
Arthralgia Arthralgia postmarketing x x x x x
Musculoskeletal discomfort Arthralgia postmarketing x x x x x
Asthenia Asthenia postmarketing x x x x x x
Atrioventricular block Atrioventricular block postmarketing x x x x x
Bronchospasm Bronchospasm postmarketing x x x x x x
Cardiovascular disorder Cardiovascular disorder postmarketing x
Connective tissue disorder Connective tissue disorder postmarketing x
Diarrhoea Diarrhoea postmarketing x x x x x x
Somnolence Drowsiness postmarketing x x x x x
Dysarthria Dysarthria postmarketing x x x x x
Slurred speech x
Osteoarthritis Dysarthria postmarketing x x x x x
Dermatitis Rash postmarketing x x x x x x
Rash Rash postmarketing x x x x x x
Muscle contractions involuntary Fasciculation postmarketing x x x x x x
Flatulence Flatulence postmarketing x x x x x
Flushing Flushing postmarketing x x x x x
Gastrointestinal disorder Gastrointestinal disorder postmarketing x
Cardiac arrest Cardiac arrest postmarketing x x x x x x
Hypersensitivity Hypersensitivity postmarketing x x x x x x
Hypotension Hypotension postmarketing x x x x x x
Mediastinal disorder Mediastinal disorder postmarketing x
Miosis Miosis postmarketing x x x x x x
Muscle spasms Cramp muscle postmarketing x x x x x x
Muscle spasms postmarketing x x x x x
Nervous system disorder Nervous system disorder postmarketing x
Abnormal behaviour Vermiculation postmarketing x x x x x x
Convulsion Convulsion postmarketing x x x x x x
Dizziness Syncope postmarketing x x x x x
Dizziness x x x x x
Shock Syncope postmarketing x x x x x
Syncope Syncope postmarketing x x x x x
Loss of consciousness Syncope postmarketing x x x x x
Loss of consciousness postmarketing x x x x x
Pollakiuria Pollakiuria postmarketing x x x x x
Urethral disorder Urinary tract disorder postmarketing x
Urinary tract disorder Urinary tract disorder postmarketing x
Urticaria Urticaria postmarketing x x x x x x
Respiratory arrest Respiratory arrest postmarketing x x x x x
Nodal rhythm Nodal rhythm postmarketing x x x x x
Respiratory depression Respiratory depression postmarketing x x x x x x
Pulmonary function test decreased Respiratory depression postmarketing x x x x x x
Hyperhidrosis Sweating increased postmarketing x x x x x x
Gastrointestinal pain Intestinal cramps postmarketing x x x x x
Abdominal pain Abdominal cramps x
Mental disorder Mental disorder x
Coma Coma x
Dyspnoea Dyspnoea x x x x x
Headache Headache x x x x x x
Nausea Nausea x x x x x x
Nystagmus Nystagmus x
Pruritus Pruritus x
Salivary hypersecretion Salivation x x x x x
Tachycardia Tachycardia x x x x x
Urinary incontinence Urinary incontinence x
Vomiting Vomiting x x x x x x
Wheezing Wheezing x
Dry mouth Dry mouth x
Agitation Agitation x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x
Chest discomfort Chest tightness x
Lacrimation increased Lacrimation x
Bradycardia Bradycardia x x x x x x
Paralysis Paralysis x
Laryngeal pain Pharyngolaryngeal pain x
Insomnia Insomnia x
Procedural complication Procedural complication x
Incision site complication Incision site complication x
Procedural nausea Post procedural nausea x
Procedural pain Procedural pain x
Post procedural complication Postoperative shivering x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

NEOSTIGMINE

Side effects:38
Source:FDA Structured Product Label

neostigmine

Side effects:38
Source:FDA Structured Product Label

neostigmine

Side effects:38
Source:FDA Structured Product Label

NEOSTIGMINE

Side effects:38
Source:FDA Structured Product Label

NEOSTIGMINE

Side effects:54
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label